Background-Bacterial lipopolysaccharide (LPS) has been proposed to participate in the pathogenesis of pancreatic inflammatory disease. Aims-This study investigated the role of endotoxaemia in the pathogenesis of pancreatic acinar cell injury. Methods-Sixty eight male SpraqueDawley rats were used in the study. Escherichia coli LPS (5 mglkg) was injected into the peritoneal cavity of the rats. The concentration of pancreatic phospholipase A2 (PLA2) in plasma was measured and pancreatic tissue examined by histology, in situ detection of free DNA 3'-ends, and electrophoretic DNA analy-
treatment.8 Moreover, infection of pancreatic tissue has been seen in caerulein induced acute pancreatitis.9 These results implicate bacterial infection of pancreatic tissue as a consequence of pancreatic disease. The role of endotoxaemia, however, in the induction of pancreatic disease is poorly understood.
Phospholipase A2 (PLA2) is an enzyme that cleaves a free fatty acid from the sn-2 position of phospholipids. PLA2 is pivotal in the initiation of arachidonic acid metabolism and formation of lysophosphatidyl choline, which is the precursor of the platelet activating factor. Pancreatic phospholipase A2 (group I PLA2) is a digestive enzyme that is synthesised and secreted by pancreatic acinar cells into the duodenal lumen.10 Increased concentrations of group I PLA2 are commonly found in serum in pancreatic diseases such as acutel1 12 and chronic pancreatitis13 14 and pancreatic cancer.12 In experimental studies, increased concentrations of group I PLA2 have been found in serum in both sodium taurocholate and caerulein induced acute pancreatitis. '5 16 The aim of this study was to investigate the role of endotoxaemia in the pathogenesis of pancreatic acinar cell injury. LPS was injected into the peritoneal cavity of rats and the rate of release of pancreatic PLA2 into the circulation was measured as a marker of acinar cell injury. In addition, changes in pancreatic histology and DNA structure were studied to detect apoptosis. Time resolvedfluoroimmunoassay (TR-FIA) for rat pancreatic PLA2 PLA2 was purified from rat pancreas and a polyclonal antibody was raised to this enzyme preparation in a rabbit as described earlier. '8 Protein A purified anti-rat pancreatic PLA2 antibody was labelled with an isothiocyanate derivative of a Europium chelate by using Eulabelling kit (Wallac, Turku, Finland) according to the manufacturer's instructions.
Methods
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TR-FIA was performed as described earlier .19 For comparison, the concentration of pancreatic PLA2 in plasma was measured by an enzyme linked immunosorbent assay (ELISA) as described earlier. ' PLA2 in plasma and pancreas In intact control rats, the concentration of pancreatic PIA2 in plasma was 60'0 (6-1) pug/l. The PLA2 concentration increased to 86-0 (6 8) ,Lg/l at three hours after LPS administration (p=0 029), remained increased at seven hours, and decreased at 24 hours (Fig 1) . There was no correlation between PIA2 activity and the concentration of pancreatic P[A2 in plasma after LPS administration (y=0O0213X+64-4, r=0-06).
The PLA2 activity of pancreatic tissue increased at one hour after LPS administration and remained increased at 72 hours (Fig 2) .
DNA analysis
Ladder-like fragmentation of pancreatic DNA typical of apoptosis was seen in pancreatic tissue homogenate 24 hours after LPS administration. DNA of animals treated with saline or seven or 72 hours after LPS administration were unfragmented (Fig 3) .
Histological examination
No histological changes were seen during the first seven hours after LPS injection; only occasional apoptotic cells were seen in the pancreas (Figs 4a and b) . Several apoptotic acinar cells with pale or eosinophilic cytoplasm and with or without fragmented nuclear material were seen 24 hours after LPS administration in the haematoxylin and eosin stained section in all animals examined (Fig 5a) . Most of these cells were positive in the in situ detection of free 3'-ends of DNA performed in adjacent sections (Fig 5b) . In control sections (0, 7, 24, or 72 hours after LPS injection), no colour reaction was noted when terminal transferase, digddUTP or antibody was omitted from the reaction mixture. Occasional apoptotic cells and autophagic vacuoles were seen in pancreatic acini three days after LPS administration. Moreover, the size of acini and the amount of cytoplasmic material in the apical zone of acini decreased because of atrophy of the exocrine pancreas (Fig 6) . No inflammatory cell infiltration was seen in the pancreas during the experiment. Fig 7) . The islet cells showed no apoptosis during the experiment.
Discussion
In this study, we show pronounced apoptosis of rat pancreatic acinar cells 24 hours after an intraperitoneal injection of LPS. Three days after the LPS injection, there was pronounced atrophy in the gland. Apoptotic fragmentation of DNA was confirmed by gel electrophoresis, which showed DNA fragments of approximately 200 The proposed mechanism of apoptosis is an initial mild plasma membrane damage with consequent influx of calcium ions28 and thereby the activation of endonucleases29 and proteases,30 which leads to apoptotic cell death. It has been assumed that, in endothelial cells, TNF induces both arachidonic acid release and apoptosis, but PLA2 activity is not involved in the induction of apoptosis.3' On the contrary, activation of PLA2 has been reported to trigger apoptosis in photosensitised mouse lymphoma cells.32
Endotoxaemia has been implicated as a prognostic factor in patients with acute haemorrhagic pancreatitis.5 6 However, the mechanisms by which bacterial endotoxins might take part in the initiation of pancreatic disease are largely unknown. Moreover, no evidence has been presented for the ability of LPS to induce apoptosis in pancreatic acinar cell. LPS prevents apoptosis of peripheral blood monocytes33 and delays apoptosis of neutrophils.34 On the contrary, apoptosis is induced by LPS in malignant CD5+ B-cells35 and in mouse thymus cells in vivo.36 A feasible pathway for the effects of LPS is the initial activation and release of TNF into circulation during the first phase of endotoxaemia followed by activation of PLA2.3 TNF is able to induce both PLA2 activity37-40 and apoptosis. 41 Suffys and coworkers proposed that PLA2 activity, but not arachidonic acid release, participates in TNF mediated cytotoxicity.42 Thus, PLA2 activation may exert cytotoxicity by non-specific hydrolysis of membrane phospholipids.
The average concentration of pancreatic PLA2 in the serum of healthy humans is 5.8 Rg/1,43 and, at the early stages of acute pancreatitis, the concentration increases up to sevenfold.12 In experimental sodium taurocholate induced acute pancreatitis in rats, the increase of pancreatic PLA2 in serum is 40-fold at 60 minutes after the induction.'5 In our study, there was 60 ,Lg/l of pancreatic PLA2 in intact rat plasma and in the plasma of saline treated control animals. The concentration increased significantly at three hours after LPS administration. These results suggest that acinar cells release pancreatic PLA2 into blood plasma during the early stages of endotoxaemia possibly caused by cell injury leading to apoptosis. The decreased concentration of pancreatic PLA2 in plasma at 24 hours after LPS administration suggests that the capability of pancreatic acinar cells to release PLA2 diminishes after apoptotic acinar cell death.
In this model of endotoxaemia, intraperitoneally injected LPS may reach pancreatic acinar cells both directly from the peritoneal cavity or after absorbtion via the bloodsteam. After intravenous administration of LPS, apoptosis can be seen in pancreatic acinar cells at 24 hours, but the number of apoptotic cells seems to be smaller than after intraperitoneal LPS administration (unpublished data). However, the time related changes in the pancreas in both models seem to be comparable (unpublished data). An intraperitoneal injection of a high dose of LPS represents the situation in which high amounts of endotoxin have an affect on the pancreas both directly and via the bloodstream, as may be the case in clinical endotoxaemia resulting from abdominal diseases. Direct and indirect effects of LPS could not be distinguished in this study. Therefore, further experiments with intravenous injection of LPS and administration of LPS to isolated pancreatic acinar cell preparation are warranted.
In summary, experimental endotoxaemia causes profound changes in rat exocrine pancreas. Pancreatic PLA2 is released into blood plasma during the first few hours before the appearance of histological changes in acinar cells. This finding supports the notion that an increased concentration of pancreatic PLA2 in plasma is an early marker of injury of pancreatic acinar cells. Apoptosis of pancreatic acinar cells is a somewhat later phenomenon. Finally, at day three after LPS administration, pancreatic acinar atrophy appears throughout the gland. The activation of PLA2 that takes place simultaneously with apoptosis in pancreatic tissue may have a role in triggering the development of apoptosis through cytokine activation. 
